FHL1 (Q13642) variants and mutations
FHL1 (also known as Q13642) is a human protein-coding gene encoding a four and a half LIM domains protein 1 protein. It organizes protein complexes in striated muscle and participates in mechanosensing, sarcomere structure, and transcriptional responses. X-linked pathogenic variants cause a spectrum including reducing-body myopathy, Emery-Dreifuss muscular dystrophy, scapuloperoneal myopathy, and cardiomyopathy. This analysis covers 630 FHL1 variants and mutations. Of these, 68% have computational variant effect predictions. Disease context includes X-linked myopathy with postural muscle atrophy, myopathy, reducing body, X-linked, early-onset, severe, and myopathy, reducing body, X-linked, childhood-onset. Example FHL1 variants include M1T, M1K, and A2T.
Variant analysis overview
- Gene: FHL1
- Protein: Q13642
- UniProt accession: Q13642
- Organism: Homo sapiens
- Variants analyzed: 630
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 374 unspecified-consequence records; 2 natural variant; 159 missense variants; 77 synonymous variants; 8 frameshift variants; 3 splice-region variants; 3 in-frame deletions; 2 in-frame insertions; 2 stop-gained variants; 2 substitution
- Prediction scores: 430 variants have prediction scores (68% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: X-linked myopathy with postural muscle atrophy, myopathy, reducing body, X-linked, early-onset, severe, myopathy, reducing body, X-linked, childhood-onset, Emery-Dreifuss muscular dystrophy, myopathy, Uruguay Faciocardiomusculoskeletal syndrome, Abnormality of the cardiovascular system, X-linked Emery-Dreifuss muscular dystrophy, angina pectoris, reducing body myopathy, myocardial ischemia, coronary atherosclerosis.
Protein structure and variant hotspots
- Protein features: 3 domains; 1 post-translational modification sites.
- Structural context: 341 variants have structural context.
- PTM context: 1 variants overlap post-translational modification sites.
- Experimental data: 60 protein positions have experimental scores. Source: FHL1 Zinc finger, LIM-type domain domainome 1.0.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable FHL1 variants
Examples include M1T, M1K, A2T, A2V, A2S, A2P, A2A, E3*. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1T (p.Met1Thr), rs2521246350, ClinGen CA414607324, ClinVar RCV003626011, Likely pathogenic, X-linked myopathy with postural muscle atrophy
- M1K (p.Met1Lys), gnomAD X-136196846-T-A, CADD 15.40
- A2T (p.Ala2Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A2V (p.Ala2Val), rs146125558, ClinGen CA10524948, NCI-TCGA Cosmic COSV6177, cosmic curated COSV61779, AlphaMissense 0.23, MetaLR 0.19, Conflicting interpretations, Cardiovascular phenotype; not specified; not provided
- A2S (p.Ala2Ser), gnomAD X-136196818-G-T, CADD 17.40
- A2P (p.Ala2Pro), rs1472956545, gnomAD X-136196827-G-C, CADD 17.40
- A2A (p.Ala2Ala), rs2073841429, gnomAD X-136206438-G-A, CADD 5.02
- E3* (p.Glu3Ter), rs2148371451, ClinGen CA414607335, ClinVar RCV001872269, Ensembl rs2148371451, Pathogenic
- K4R (p.Lys4Arg), rs1230410861, ClinGen CA414607346, ClinVar RCV000823871, ClinVar RCV002501146, AlphaMissense 0.08, MetaLR 0.05, Uncertain significance, not provided; X-linked scapuloperoneal muscular dystrophy; Myopathy, reducing bo
- F5L (p.Phe5Leu), rs2073841797, ClinGen CA414607357, ClinVar RCV001324032, TOPMed rs2073841797, AlphaMissense 0.97, MetaLR 0.36, Uncertain significance, X-linked myopathy with postural muscle atrophy
- D6E (p.Asp6Glu), ExAC rs748075349, gnomAD rs748075349
- C7* (p.Cys7Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- C7F (p.Cys7Phe), rs2073842039, ClinGen CA414607380, ClinVar RCV001209274, ClinVar RCV005340670, AlphaMissense 1.00, MetaLR 1.00, Uncertain significance, Cardiovascular phenotype; X-linked myopathy with postural muscle atrophy
- C7R (p.Cys7Arg), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10060, Uncertain significance, FHL1-related disorder; Cardiovascular phenotype
- H8Q (p.His8Gln), rs2521246943, ClinGen CA414607397, ClinVar RCV002761220, Uncertain significance, X-linked myopathy with postural muscle atrophy
- H8Y (p.His8Tyr), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10060, Variant assessed as somatic; moderate impact.
- H8R (p.His8Arg), rs1373896210, gnomAD X-136197123-A-G, REVEL 0.13, CADD 14.80
- H8H (p.His8His), rs758985965, gnomAD X-136197124-T-C, CADD 0.38
- H8N (p.His8Asn), gnomAD X-136197128-C-A, REVEL 0.03, CADD 11.10
- H8P (p.His8Pro), gnomAD X-136197129-A-C, REVEL 0.11, CADD 14.00
- Y9H (p.Tyr9His), Ensembl rs2073842134
- Y9S (p.Tyr9Ser), rs2521247083, ClinGen CA414607408, ClinVar RCV004511013, Uncertain significance, Cardiovascular phenotype
- Y9C (p.Tyr9Cys), rs781161801, gnomAD X-136196813-A-G, CADD 15.80
- C10F (p.Cys10Phe), cosmic curated COSV10886, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- C10R (p.Cys10Arg), rs2148371530, ClinGen CA414607420, ClinVar RCV001960000, Ensembl rs2148371530, AlphaMissense 1.00, MetaLR 1.00, Uncertain significance, X-linked myopathy with postural muscle atrophy
- C10Y (p.Cys10Tyr), rs2148371537, ClinGen CA414607428, ClinVar RCV001921309, ClinVar RCV002441046, AlphaMissense 1.00, MetaLR 1.00, Uncertain significance, Myopathy, reducing body, X-linked, childhood-onset; X-linked myopathy with postu
- R11K (p.Arg11Lys), rs1449701149, ClinGen CA414607438, ClinVar RCV003177272, TOPMed rs1449701149, AlphaMissense 0.29, MetaLR 0.51, Uncertain significance, Cardiovascular phenotype
- R11M (p.Arg11Met), NCI-TCGA Cosmic COSV6177, cosmic curated COSV61779, Variant assessed as somatic; moderate impact.
- D12E (p.Asp12Glu), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10060, Variant assessed as somatic; moderate impact.
- D12Y (p.Asp12Tyr), Ensembl rs2148371568
- P13R (p.Pro13Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P13P (p.Pro13Pro), rs1270437936, gnomAD X-136196859-C-T, CADD 9.83
- P13S (p.Pro13Ser), gnomAD X-136206409-C-T, REVEL 0.13, CADD 15.20
- L14F (p.Leu14Phe), rs2521247546, ClinGen CA414607489, ClinVar RCV003410886, Uncertain significance, FHL1-related disorder
- L14M (p.Leu14Met), gnomAD X-136196824-C-A, CADD 17.30
- L14P (p.Leu14Pro), gnomAD X-136196825-T-C, CADD 18.40
- L14L (p.Leu14Leu), gnomAD X-136196830-C-T, CADD 16.60
- Q15E (p.Gln15Glu), rs2521247645, ClinGen CA414607493, ClinVar RCV003625313, Uncertain significance, X-linked myopathy with postural muscle atrophy
- G16S (p.Gly16Ser), rs370725689, gnomAD X-136197134-G-A, REVEL 0.18, CADD 18.80
- G16D (p.Gly16Asp), gnomAD X-136206407-G-A, REVEL 0.26, CADD 21.80
- G16V (p.Gly16Val), gnomAD X-136206407-G-T, REVEL 0.23, CADD 22.50
- K17R (p.Lys17Arg), TOPMed rs1245907750, gnomAD rs1245907750
- Y19* (p.Tyr19Ter), rs2521247887, ClinGen CA2580101557, ClinVar RCV002825374, Pathogenic
- Y19S (p.Tyr19Ser), TOPMed rs2073842642
- V20V (p.Val20Val), gnomAD X-136196817-G-A, CADD 17.70
- V20L (p.Val20Leu), gnomAD X-136206424-G-T, REVEL 0.09, CADD 18.10
- V20M (p.Val20Met), gnomAD X-136206424-G-A, REVEL 0.08, CADD 18.10
- Q21E (p.Gln21Glu), TOPMed rs1301872071, gnomAD rs1301872071
- Q21R (p.Gln21Arg), rs1187549360, ClinGen CA414607587, ClinVar RCV001220807, ClinVar RCV003145411, AlphaMissense 0.30, MetaLR 0.45, Uncertain significance, not provided; X-linked myopathy with postural muscle atrophy
- Q21P (p.Gln21Pro), gnomAD X-136206494-A-C, REVEL 0.42, CADD 21.50
- K22N (p.Lys22Asn), NCI-TCGA TCGA novel, 1000Genomes rs140149764, ESP rs140149764, ExAC rs140149764, Benign
- K22T (p.Lys22Thr), rs1370793393, ClinGen CA414607601, ClinVar RCV001730314, ClinVar RCV004616764, AlphaMissense 0.90, MetaLR 0.78, Uncertain significance, Cardiovascular phenotype
- D23V (p.Asp23Val), Ensembl rs2073843516
- D23E (p.Asp23Glu), rs748075349, gnomAD X-136206450-C-G, REVEL 0.12, CADD 17.20
- G24C (p.Gly24Cys), ExAC rs772911535, TOPMed rs772911535, gnomAD rs772911535, Uncertain significance
- G24D (p.Gly24Asp), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10060, Variant assessed as somatic; moderate impact.
- G24S (p.Gly24Ser), rs772911535, ClinGen CA10524951, cosmic curated COSV61781, ClinVar RCV001373015, AlphaMissense 0.18, MetaLR 0.70, Uncertain significance, Cardiovascular phenotype; X-linked myopathy with postural muscle atrophy
- G24W (p.Gly24Trp), gnomAD X-136206478-G-T, REVEL 0.89, CADD 29.10
- G24R (p.Gly24Arg), gnomAD X-136206478-G-A, REVEL 0.88, CADD 27.60
- H25Y (p.His25Tyr), rs1569530250, ClinGen CA414607641, ClinVar RCV000685448, Ensembl rs1569530250, AlphaMissense 0.16, MetaLR 0.58, Uncertain significance, X-linked myopathy with postural muscle atrophy
- H26Q (p.His26Gln), TOPMed rs1305364903, gnomAD rs1305364903
- C27R (p.Cys27Arg), Ensembl rs11557265
- C27W (p.Cys27Trp), rs2521248920, ClinGen CA414607676, ClinVar RCV004511016, NCI-TCGA TCGA novel, Uncertain significance, Cardiovascular phenotype
- L29L (p.Leu29Leu), rs1313810606, gnomAD X-136206472-T-C, CADD 11.10
- L29F (p.Leu29Phe), gnomAD X-136206474-G-T, REVEL 0.88, CADD 23.80
- K30R (p.Lys30Arg), rs1226091388, ClinGen CA414607707, ClinVar RCV001069701, ClinVar RCV004768852, AlphaMissense 0.08, MetaLR 0.41, Uncertain significance, not provided; X-linked myopathy with postural muscle atrophy
- C31L (p.Cys31Leu), rs2148371771, ClinGen CA2573159299, ClinVar RCV001889242, Ensembl rs2148371771, Uncertain significance, X-linked myopathy with postural muscle atrophy
- C31R (p.Cys31Arg), rs2521249141, ClinGen CA414607712, ClinVar RCV002304040, Uncertain significance, X-linked myopathy with postural muscle atrophy
- F32S (p.Phe32Ser), rs2521249242, ClinGen CA414607723, ClinVar RCV003035572, Uncertain significance, X-linked myopathy with postural muscle atrophy
- F32Y (p.Phe32Tyr), rs2521249242, ClinGen CA414607722, ClinVar RCV003624170, Uncertain significance, X-linked myopathy with postural muscle atrophy
- D33G (p.Asp33Gly), rs1207531202, ClinGen CA414607731, ClinVar RCV003042311, AlphaMissense 0.91, MetaLR 0.72, Uncertain significance, X-linked myopathy with postural muscle atrophy
- D33H (p.Asp33His), NCI-TCGA Cosmic COSV6178, cosmic curated COSV61780, Variant assessed as somatic; moderate impact.
- D33N (p.Asp33Asn), Ensembl rs2073844441
- D33V (p.Asp33Val), TOPMed rs1207531202, gnomAD rs1207531202
- K34E (p.Lys34Glu), rs754421860, ClinGen CA414607736, ClinVar RCV000788887, ClinVar RCV002535794, AlphaMissense 0.71, MetaLR 0.74, Uncertain significance, Cardiovascular phenotype; X-linked myopathy with postural muscle atrophy
- K34N (p.Lys34Asn), rs1265392418, ClinGen CA414607741, ClinVar RCV002653481, Ensembl rs1265392418, AlphaMissense 0.93, MetaLR 0.69, Uncertain significance, X-linked myopathy with postural muscle atrophy
- K34Q (p.Lys34Gln), rs754421860, ClinGen CA336093911, ClinVar RCV001957638, ClinVar RCV005565040, AlphaMissense 0.71, MetaLR 0.74, Uncertain significance, Cardiovascular phenotype; X-linked myopathy with postural muscle atrophy
- K34del (p.Lys34del), gnomAD X-136206479-GGAA-, CADD 20.40
- K34R (p.Lys34Arg), rs1245907750, gnomAD X-136206482-A-G, REVEL 0.52, CADD 24.60
- K34T (p.Lys34Thr), rs1370793393, gnomAD X-136206497-A-C, REVEL 0.62, AlphaMissense 0.90
- K34K (p.Lys34Lys), rs140149764, gnomAD X-136206498-G-A, CADD 11.60
- F35L (p.Phe35Leu), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10060, Variant assessed as somatic; moderate impact.
- C36* (p.Cys36Ter), rs368235882, ClinGen CA414607756, ClinVar RCV003035176, Pathogenic
- C36S (p.Cys36Ser), TOPMed rs2073844993, gnomAD rs2073844993
- A37V (p.Ala37Val), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10060, Variant assessed as somatic; moderate impact.
- A37R (p.Ala37Arg), rs1300291330, gnomAD X-136196858-C-CT, CADD 11.30
- A37T (p.Ala37Thr), rs192893870, gnomAD X-136196860-G-A, CADD 13.10
- A37A (p.Ala37Ala), rs1415924555, gnomAD X-136196862-A-G, CADD 21.40
- N38S (p.Asn38Ser), rs886043917, ClinGen CA10606110, ClinVar RCV000343087, ClinVar RCV001202211, AlphaMissense 0.20, MetaLR 0.81, Uncertain significance
- N38Y (p.Asn38Tyr), NCI-TCGA Cosmic COSV6178, cosmic curated COSV61780, Variant assessed as somatic; moderate impact.
- T39N (p.Thr39Asn), gnomAD rs1252282869
- T16del (p.Thr16del), rs1356932748, gnomAD X-136206428-GCAC-, CADD 17.50
- T39S (p.Thr39Ser), rs769992006, gnomAD X-136206431-C-G, REVEL 0.13, CADD 18.60
- C40R (p.Cys40Arg), rs2148371880, ClinGen CA414607779, ClinVar RCV001365191, Ensembl rs2148371880, AlphaMissense 1.00, MetaLR 0.99, Uncertain significance, X-linked myopathy with postural muscle atrophy
- C40Y (p.Cys40Tyr), rs1556638703, ClinGen CA414607780, ClinVar RCV000658161, ClinVar RCV000707679, AlphaMissense 1.00, MetaLR 0.99, Uncertain significance, X-linked myopathy with postural muscle atrophy; not provided
- V41E (p.Val41Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V41M (p.Val41Met), ExAC rs776249397, gnomAD rs776249397
- V41V (p.Val41Val), rs2073842775, gnomAD X-136206492-G-A, CADD 11.10
- C43* (p.Cys43Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- C43S (p.Cys43Ser), gnomAD X-136206512-G-C, REVEL 0.43, CADD 21.40
- C43Y (p.Cys43Tyr), gnomAD X-136206524-G-A, REVEL 0.82, CADD 27.20
- C43C (p.Cys43Cys), gnomAD X-136206525-C-T, CADD 12.80
- R44C (p.Arg44Cys), rs1385440296, ClinGen CA414607808, cosmic curated COSV61781, ClinVar RCV002385406, AlphaMissense 0.35, MetaLR 0.78, Uncertain significance, not provided; Cardiovascular phenotype; X-linked myopathy with postural muscle a
- R44H (p.Arg44His), rs11557264, ClinGen CA336093951, ClinVar RCV000615985, ClinVar RCV001237713, AlphaMissense 0.71, MetaLR 0.73, Conflicting interpretations, Cardiovascular phenotype; not specified; X-linked myopathy with postural muscle
- R44L (p.Arg44Leu), TOPMed rs11557264, gnomAD rs11557264, Likely benign
- K45R (p.Lys45Arg), rs1226091388, gnomAD X-136206521-A-G, REVEL 0.22, AlphaMissense 0.08
- P46S (p.Pro46Ser), cosmic curated COSV10060, ExAC rs759110550, gnomAD rs759110550
- I47F (p.Ile47Phe), rs2073846647, ClinGen CA414607824, ClinVar RCV003301917, AlphaMissense 0.27, MetaLR 0.83, Uncertain significance, Cardiovascular phenotype
- I47V (p.Ile47Val), TOPMed rs2073846647
- I47T (p.Ile47Thr), gnomAD X-136196840-T-C, CADD 19.10
- I47I (p.Ile47Ile), gnomAD X-136196841-T-C, CADD 19.10
- G48R (p.Gly48Arg), TOPMed rs1467233713, gnomAD rs1467233713, Uncertain significance
- G48S (p.Gly48Ser), rs1467233713, ClinGen CA414607830, NCI-TCGA Cosmic COSV6178, AlphaMissense 0.14, MetaLR 0.46, Uncertain significance, Cardiovascular phenotype; not provided; X-linked myopathy with postural muscle a
- G48V (p.Gly48Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G48D (p.Gly48Asp), gnomAD X-136206575-G-A, REVEL 0.57, CADD 24.20
- A49V (p.Ala49Val), rs372301312, ClinGen CA10524956, NCI-TCGA Cosmic COSV6177, cosmic curated COSV61779, AlphaMissense 0.33, MetaLR 0.47, Uncertain significance, X-linked myopathy with postural muscle atrophy; not provided
- A49A (p.Ala49Ala), rs1458693544, gnomAD X-136206543-C-T, CADD 14.20
- D50E (p.Asp50Glu), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10060, Variant assessed as somatic; moderate impact.
- D50N (p.Asp50Asn), NCI-TCGA Cosmic COSV6178, cosmic curated COSV61782, Variant assessed as somatic; moderate impact.
- D50G (p.Asp50Gly), gnomAD X-136206530-A-G, REVEL 0.83, CADD 25.90
- D50V (p.Asp50Val), rs1207531202, gnomAD X-136206530-A-T, REVEL 0.82, AlphaMissense 0.91
- S51C (p.Ser51Cys), TOPMed rs1327221666, gnomAD rs1327221666, Uncertain significance
- S51F (p.Ser51Phe), rs1327221666, ClinGen CA414607853, ClinVar RCV001964274, TOPMed rs1327221666, AlphaMissense 0.47, MetaLR 0.83, Uncertain significance, X-linked myopathy with postural muscle atrophy
- S51P (p.Ser51Pro), rs2521251136, ClinGen CA414607850, ClinVar RCV003624195, ClinVar RCV004810532, Uncertain significance, not provided; X-linked myopathy with postural muscle atrophy
- S51T (p.Ser51Thr), rs745876962, gnomAD X-136196821-T-A, CADD 18.40
- S51E (p.Ser51Glu), gnomAD X-136196848-C-CT, CADD 16.70
- S51R (p.Ser51Arg), rs1199845428, gnomAD X-136196850-GAGTA, CADD 16.50
- S51N (p.Ser51Asn), rs1490753415, gnomAD X-136196852-G-A, CADD 18.10
- S51S (p.Ser51Ser), rs1401608328, gnomAD X-136196853-T-C, CADD 18.70
- K52Q (p.Lys52Gln), rs754421860, gnomAD X-136206532-A-C, REVEL 0.59, AlphaMissense 0.71
- K52E (p.Lys52Glu), rs754421860, gnomAD X-136206532-A-G, REVEL 0.44, AlphaMissense 0.71
- K52K (p.Lys52Lys), gnomAD X-136206534-G-A, CADD 12.10
- V54M (p.Val54Met), rs776249397, gnomAD X-136206553-G-A, REVEL 0.40, CADD 23.10
- H55Y (p.His55Tyr), rs1603270864, ClinGen CA414607891, ClinVar RCV000856703, Ensembl rs1603270864, AlphaMissense 0.27, MetaLR 0.59, Uncertain significance, Muscle weakness
- H55Q (p.His55Gln), rs1305364903, gnomAD X-136206510-C-G, REVEL 0.24, CADD 17.20
- H55H (p.His55His), rs1305364903, gnomAD X-136206510-C-T, CADD 10.50
- Y56* (p.Tyr56Ter), rs2073860048, ClinGen CA414607901, ClinVar RCV001215729, Ensembl rs2073860048, Pathogenic
- Y56C (p.Tyr56Cys), rs758269641, ClinGen CA10524967, ClinVar RCV000805795, ClinVar RCV005562471, AlphaMissense 0.58, MetaLR 0.75, Uncertain significance, Cardiovascular phenotype; not provided; X-linked myopathy with postural muscle a
- Y56F (p.Tyr56Phe), rs758269641, ClinGen CA414607900, ClinVar RCV003019357, AlphaMissense 0.58, MetaLR 0.75, Uncertain significance, X-linked myopathy with postural muscle atrophy
- Y56H (p.Tyr56His), ExAC rs749348637, gnomAD rs749348637
- Y56Y (p.Tyr56Tyr), gnomAD X-136207027-T-C, CADD 5.27
- K57E (p.Lys57Glu), gnomAD X-136206565-A-G, REVEL 0.67, CADD 23.20
- N58K (p.Asn58Lys), rs1471334826, ClinGen CA414607917, ClinVar RCV004328501, Uncertain significance, Cardiovascular phenotype
- N58S (p.Asn58Ser), rs886043917, gnomAD X-136206545-A-G, REVEL 0.72, AlphaMissense 0.20
- R59C (p.Arg59Cys), rs1343871742, ClinGen CA414607920, ClinVar RCV000646183, ClinVar RCV003144424, AlphaMissense 0.91, MetaLR 0.74, Uncertain significance, Cardiovascular phenotype; not provided; X-linked myopathy with postural muscle a
- R59G (p.Arg59Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R59H (p.Arg59His), cosmic curated COSV10591, Ensembl rs2148373188
- R59S (p.Arg59Ser), TOPMed rs1343871742, gnomAD rs1343871742, Uncertain significance, Cardiovascular phenotype; X-linked myopathy with postural muscle atrophy
- F60L (p.Phe60Leu), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10060, Variant assessed as somatic; moderate impact.
- F60F (p.Phe60Phe), gnomAD X-136206528-T-C, CADD 11.20
- H62R (p.His62Arg), Ensembl rs11557267
- D63D (p.Asp63Asp), gnomAD X-136206582-C-T, CADD 8.16
- T64I (p.Thr64Ile), rs746834335, ClinGen CA10524969, ClinVar RCV000705173, ExAC rs746834335, AlphaMissense 0.08, MetaLR 0.37, Uncertain significance, X-linked myopathy with postural muscle atrophy
- T64N (p.Thr64Asn), rs746834335, ClinGen CA336094288, ClinVar RCV001040158, ClinVar RCV002409384, AlphaMissense 0.08, MetaLR 0.37, Conflicting interpretations, X-linked myopathy with postural muscle atrophy; Myopathy, reducing body, X-linke
- T64S (p.Thr64Ser), gnomAD X-136206548-C-G, REVEL 0.48, CADD 20.10
- T64T (p.Thr64Thr), rs770499208, gnomAD X-136206549-C-T, CADD 11.80
- C65* (p.Cys65Ter), rs777580253, ClinGen CA414607967, ClinVar RCV001383795, ExAC rs777580253, Pathogenic
- C65C (p.Cys65Cys), rs1192668098, gnomAD X-136206552-T-C, CADD 6.75
- F66L (p.Phe66Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F66S (p.Phe66Ser), gnomAD rs1412410064, Uncertain significance, X-linked myopathy with postural muscle atrophy
- R67C (p.Arg67Cys), rs1379221574, ClinGen CA414607979, NCI-TCGA Cosmic COSV6178, cosmic curated COSV61780, AlphaMissense 0.21, MetaLR 0.78, Conflicting interpretations, not specified; X-linked scapuloperoneal muscular dystrophy; X-linked myopathy wi
- R67H (p.Arg67His), rs745544703, ClinGen CA10524972, cosmic curated COSV10591, ClinVar RCV001858826, AlphaMissense 0.11, MetaLR 0.60, Uncertain significance, X-linked myopathy with postural muscle atrophy; Cardiovascular phenotype; not pr
- R67S (p.Arg67Ser), rs1343871742, gnomAD X-136207034-C-A, REVEL 0.90, AlphaMissense 0.91
- R67G (p.Arg67Gly), gnomAD X-136207034-C-G, REVEL 0.87, CADD 23.10
- R67R (p.Arg67Arg), rs143791173, gnomAD X-136207036-C-A, CADD 13.80
- A69G (p.Ala69Gly), rs2521263387, ClinGen CA414607993, ClinVar RCV003147265, Uncertain significance, not provided
- A69T (p.Ala69Thr), rs139625615, ClinGen CA10524973, ClinVar RCV000646185, ClinVar RCV002422347, AlphaMissense 0.09, MetaLR 0.55, Uncertain significance, Cardiovascular phenotype; not provided; X-linked myopathy with postural muscle a
- A69V (p.Ala69Val), rs372301312, gnomAD X-136206578-C-T, REVEL 0.26, AlphaMissense 0.33
- A69A (p.Ala69Ala), rs1394298803, gnomAD X-136206579-G-A, CADD 3.02
- K70N (p.Lys70Asn), rs2073861633, ClinGen CA414608001, ClinVar RCV001298028, Ensembl rs2073861633, AlphaMissense 0.87, MetaLR 0.71, Uncertain significance, X-linked myopathy with postural muscle atrophy
- K70K (p.Lys70Lys), gnomAD X-136207030-G-A, CADD 13.60
- C71* (p.Cys71Ter), rs886044238, ClinGen CA10606517, ClinVar RCV000432968, ClinVar RCV005895878, Pathogenic
- C71R (p.Cys71Arg), rs2148373315, ClinGen CA414608004, ClinVar RCV002019454, Ensembl rs2148373315, AlphaMissense 1.00, MetaLR 1.00, Uncertain significance, X-linked myopathy with postural muscle atrophy
- L72P (p.Leu72Pro), rs2521263688, ClinGen CA414608015, ClinVar RCV002712117, Uncertain significance, X-linked myopathy with postural muscle atrophy
- H73Y (p.His73Tyr), gnomAD rs2073861948
- H73H (p.His73His), rs917304507, gnomAD X-136207024-C-T, CADD 9.59
- P74R (p.Pro74Arg), gnomAD rs1316132670, Uncertain significance, X-linked myopathy with postural muscle atrophy
- P74S (p.Pro74Ser), rs774990626, ClinGen CA414608025, ClinVar RCV002609074, ExAC rs774990626, AlphaMissense 0.14, MetaLR 0.37, Uncertain significance, X-linked myopathy with postural muscle atrophy
- P74T (p.Pro74Thr), ExAC rs774990626, gnomAD rs774990626, Uncertain significance
- P74P (p.Pro74Pro), gnomAD X-136206570-C-T, CADD 12.50
Public FHL1 analysis runs
- FHL1 analysis run — FHL1 (630 variants) — completed 2026-08-21